Resurgence of COVID-19 cases serious concern: Centre
‘Clinical trial mode’ condition of Covaxin manufactured by Bharat Biotech International taken off; Covaxin granted licence similar to …
Bhopal Covaxin trial participants allege side-effects, irregularities
Bhopal-based rights group writes to PM and Union health minister, demanding that ongoing Covaxin trial be halted there
Coronavirus vaccine: Why it’s important to know what’s in the placebo
Adding an actual vaccine to the placebo control helps the trial remain blinded and prevents bias arising from differing expectations
Guillain-Barre: What is this neurological disorder — and how is it linked to COVID-19
Ninety-day national health emergency in Peru after 182 GBS cases reported since June 2023
Rwanda: 8 health workers arrested for stealing COVID-19 vaccines, test kits
The accused are employees of 4 health facilities in the country’s western and southern provinces
Omicron variant: How should India deal with a fresh surge in COVID-19 cases?
India reported 1,700 omicron cases as of January 3
Moderna’s brazen patent grab on a COVID-19 jab
The US administration is finally putting its foot down on the appropriation of public research by drug firms
G20 Summit: 7 COVID-19 deaths every minute, rich countries urged to share soon-expiring vaccines
By the end of October, US, EU, Britain and Canada would have a stock of 240 million unused vaccines
Less than 10% of African countries likely to hit COVID-19 vaccination goal
The continent has so far fully vaccinated only 6% of its population; 70% of high-income countries have vaccinated more than 40% of their populations
COVID-19: Vaccine export to resume from next month, says Mandaviya
More than 300 million doses will be produced in October and more than a billion in the next quarter, according to Mansukh Mandaviya
COVID-19 vaccine weekly: Sharing doses tops the G7 agenda
Nepal has seen a surge in cases but has only vaccinated 2.5% of its population; Peru has the highest COVID-19 death rate per head of …
Who should or shouldn’t take the COVID-19 vaccine
The demand for vaccination has suddenly grown manifold after the devastating second wave of COVID-19. But there are many myths and misconceptions …
It will be months before there is consensus over COVID-19 vaccine patents: Experts
The United States has supported a temporary waiver on COVID-19 vaccine patents; but not all is hunky-dory, say experts
What South Africans should know, but don’t, about government’s COVID-19 vaccine procurement
Uncertainty remains around the exact role of South Africa’s nine provinces, each with its own legislature and executive council, on …
Intellectual property and COVID-19 medicines: Why a WTO waiver may not be enough
A waiver might not allow all developing countries to secure medicines and other anti-COVID technologies in a timely way
What Tanzania’s COVID-19 vaccine reluctance means for its citizens and the world
Only a few months into the pandemic, the president declared Tanzania COVID-free following three days of national prayers. The argument was that …
Here’s the first Africa-wide survey of the economic impact of COVID-19 on cultural industries
There are factors explaining the harsh impact of the pandemic on cultural industries in Africa. These range from levels of informality and the …
Self-sufficient Africa: Rwanda gets continent’s first unit for mRNA vaccine production
Containers of mRNA mobile factories called Biontainers to boost African vaccine production
Omicron can partially evade vaccines, booster dose needed : Studies
Vaccinated persons who had contracted COVID-19 in the past have better protection against the disease
Omicron ‘re-infection’ raises questions about waning immunity against COVID-19. Here’s what we know
The metric being currently used to test waning immunity is an antibody test. Immunologists, however, have cautioned against an overreaction to …
Trade barriers, raw material scarcity can dent hopes for 10 billion COVID-19 vaccines in production
Experts warned of short supply of crucial raw materials; late delivery of bio-reactor giant plastic bags can set back production by weeks, …
COVID-19: Zydus Cadila seeks emergency approval of its needleless vaccine
This needleless vaccine, in case it gets approval, will be the world’s first plasmid deoxyribonucleic acid vaccine against COVID-19 …
COVID-19 vaccination drive hits a pause in Odisha’s 11 districts
After administering 0.3 million doses June 21, the state has run out of vaccines; the drive expected to resume July 2
COVID-19: Vaccine shortage hits much-hyped vaccination drive in Bihar
At the current rate of vaccination, the state will take up to two years to inoculate all its 128 million people, experts say
COVID-19 vaccine update: SC quizzes Centre on mandatory online registration, dual pricing
You keep saying digital India, digital India, but you are not aware of the ground realities: Justice Chandrachud